The legacy companies within our industry are not looking for a minimum increase in market share when evaluating a potential acquisition. They are seeking an established product portfolio that will further strengthen their position in hips, knees, trauma and spine, at least the companies that tout themselves as offering the option of "one-stop" shopping. So where does that leave Zimmer?
Zimmer Spine leaves much to the imagination in terms of a product portfolio. Spine Tech and Spinal Concepts still has not placed them on the same ground that their legacy company breathrens stand on. Our guess is that at best the Big Z is sniffing around or window shopping at best. TSB wants to know if anyone has heard otherwise?